Consideraciones terapéuticas en pacientes con leucemia aguda en la era COVID-19

Ramos-Peñafiel, Christian O.; Zapata-Canto, Nidia P.; Demichelis-Gómez, Roberta; Álvarez-Vera, José L.; Arana-Luna, Luara L.; Peña-Celaya, José A. De La; Espitia-Ríos, María E.; Hernández-Ruiz, Eleazar; Pérez-Zúñiga, Juan M.; Alvarado-Ibarra, Martha.
Gac. méd. Méx ; 157(supl.3): S29-S34, feb. 2021. tab
Artículo en Español | LILACS-Express | ID: biblio-1375499

Documentos relacionados

  1. Supramolecular assembly of GSK3α as a cellular response to amino acid starvation.
  2. Pooled testing for SARS-CoV-2, options for efficiency at scale.
  3. Infección por SARS-CoV2 en pacientes con trasplante de órgano sólido: Cinco preguntas importantes
  4. Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring.
  5. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
  6. Surveillance for variants of SARS-CoV-2 to inform risk assessments.
  7. Design aspects of COVID-19 treatment trials: Improving probability and time of favorable events.
  8. Love in the time of COVID-19: A brief report on relationship and individual functioning among committed couples in the United States while under shelter-in-place orders.
  9. Host Recovery from Respiratory Viral Infection.
  10. Burden of Severe 2009 Pandemic Influenza A (H1N1) Infection in Children in Southeast Spain